Point of Care Strep Tests Speed Treatment, Lower Costs
...king this assay the most broadly produced point of care diagnostic kit. Among the most popular RADT produc...has become a ubiquitous improvement in the primary care setting and, research findings indicate, has contributed to timely, cost-effective patient care....Rapid Whole Blood Testing for Infectious Mononucleosis Antibodies
... quickly remove uncertainty and hasten appropriate care for infected individuals....Fast, Accurate Influenza A/B Antigen Detection
... by the availability of rapid testing for point of care use. Early diagnosis of influenza can reduce the u...ding an important diagnostic resource for point of care use. All of these kits are characterized by the College of American Pathologists as moderately compl...PSA TestingHow Much is Too Much?
...rformed, self-contained kits suitable for point of care use, to mail-in specimen collection kits available for clinical or home screenings. Bio-Quant, Inc., San Diego, Calif., manufactures the OneStep PSA InstaTest designed to detect PSA concentration in whole blood or serum in concentrations as low as fo...Monitoring Options Expand for Therapeutic Agents and Drugs of Abuse
...le many simple test kits are suitable for point of care use by medical professionals or for, home and work...rms produce test kits that can be used in point of care settings to monitor drug free status or in the pre-employment setting to rule out illegal drug use. ...Prothrombin Time Comes in Small (CLIA-Waived) Packages
...devices, allowing rapid assessment in the point of care setting, and, in the cases of several waived-devic...oduces the CoaguChek S System, designed for health care professionals to enable on-the-spot analysis of coagulation levels during mobile emergency treatment...Rapid Flu Tests May Prove Especially Helpful This Season
... residents of nursing homes the elderly and health care workers and caregivers. 2. Encourage reasonable hygiene precautions for everyone, including frequent and thorough hand washing. People are also being urged to remain home if they are experiencing flu-like symptoms. 3. Assiduously identify, track and ...Lab Automation Networks Proliferating
...he difficult financial challenges of modern health care and the quest for improved quality and resourcefulness, the spread of automation appears inevitable and highly desirable....Analyzers Offer Point-of-Care Lipid Panels
...aived, making their use a practical enhancement of care for point-of-care settings like physician offices ...alues will continue to expand as a routine patient care activity. At the same time, the widespread competition in this field will likely yield even faster, ...Genetic Analysis Systems Enter the Clinical Mainstream
...t kits are becoming available for primary point of care locations such as clinics and physician offices. T...etic assessment into the realm of routine clinical care for the first time. By automating the entire testing process in a self-contained closed cartridge, t......itial antibiotic treatment, infections with health care associated MRSA result in increased costs and wors...in ICU settings. MRSA is also common in long-term care facilities. MRSA may colonize mucosal or epithelial surfaces, the most common colonized site being t...Point of Care Cardiac Analyzers Yield Rapid Cardiac Marker Results
...inutes. With regard to TAT, quantitative point of care (POC) assays that directly assay whole blood provi...oche Diagnostic Systems have FDA approved point of care technology to measure cardiac markers. The indications for use are for rapid quantitative measureme...Tight Glycemic Control in the ICU
...nesses for which patients are treated in intensive care units (ICUs) has not improved dramatically over th...ndeed, critically ill patients requiring intensive care for more than five days have a 20 percent risk of death and substantial morbidity. Recently, howeve...Diagnosing Diabetes: Immediate HbA1c Results Improve Glycemic Control
... to be $132 billion, or one out of every 10 health care dollars spent in the United States. A chronic disease with no cure, diabetes is a group of diseases (including Type 1, Type 2, and gestational) marked by high levels of blood glucose resulting from defects in insulin production, insulin action, or bo...Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
...f chemotherapy. It is difficult to imagine medical care without this workhorse device, and surprising to learn its origins. Early testing of sonar, developed to detect submarines during World War II, revealed odd underwater echoes. To determine the cause, an electrical engineer was tasked with counting pl...Blood Gas Analysis: The Pros and Cons of Point-Of-Care Testing
... analyzers are located in or near selected patient care settings, such as intensive care units (ICUs), operating rooms (ORs) and emergency departments. Because ABGs are the most common test...Rapid HIV Testing Increases Possibility of Treatment
...ations where people routinely obtain their medical care is fundamental to such progress and the use of devices such as those reported here will bring great benefit to many people in this urgent disease crisis....Near-Patient Testing: The Advantages of C-Reactive Protein in Hematological Testing
...lization becomes a necessity throughout the health care sector, it is apparent that such areas of frequent...economic benefits in addition to improving patient care and prognosis. The percentage of unjustified red blood cell or platelet transfusions can potentiall...Urinalysis Analyzers: Large Capabilities in Every Size Device
..., Tarrytown, N.Y., a division of the German health care giant, has been a leader in this diagnostic field for many years. The firm developed the first in vitro diagnostic kit, CLINITEST Reagent Tablets, in 1941, and the first dip-and-read test for glucose, CLINISTIX Reagent Strips, in 1956. Bayer current...Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
...rapy as compared to thosereceiving best supportive care or chemotherapy alone based onongoing, controlled ...ncer therapies that are animportant cornerstone of care today. Hundreds of scientists atBristol- Myers Squibb's Pharmaceutical Research Institute arestudyin......sknown as EGFR inhibitors. This ongoing supportive care trial islisted on the National Cancer Institute Clinical Trials website(www.cancer.gov). Paul Miller, President of MPM Medical, stated, "EGFR inhibitorsform a group of drugs, sold by several pharmaceutical companies,which are effective in the treatme...Antibiotics Don't Prevent Future Urinary Tract Infections, May Cause Resistance in Future Infections
...e study of children diagnosed with UTI in aprimary care pediatric setting, researchers from The Children's...th funding. In addition, its uniquefamily-centered care and public service programs have brought the430-bed hospital recognition as a leading advocate for c...New Information on the Potential of Plasmin Shared at ISTH Congress
...pany that discovers, develops and producescritical care treatments for people with life-threatening disordersin a variety of therapeutic areas including immunology,pulmonology, and hemostasis. Talecris is proudly building upon a60-year legacy of innovation and a commitment to improving thelives of people ...Corgenix Reports New Clinical Data Correlating AtherOx Technology With Vascular Disease
...otential to become an importantaddition to medical care worldwide." "These findings indicate important relationships between AtherOxand the severity of cardiovascular disease," added Dr. Lopez. "Wehope to have the ability to match patients with a treatment thatmay improve their survival, and if borne out...Molecular Target of Bradmer's Neuradiab Further Validated by Independent Findings
...argest healthcare markets. The current standard of care forGBM patients is surgical resection followed by radiation andtemozolomide. GBM tumors typically have infiltrating edges that arevery difficult to completely remove with surgery. The Neuradiabtherapy is delivered directly into the surgical resection...Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
...,endocrinologists, orthopedists and select primary care physicians.Auxilium markets Testim(R) 1%, a topical testosterone gel, for thetreatment of hypogonadism through its approximately 190-personsales and marketing team. Auxilium has four projects in clinicaldevelopment. AA4500, an injectable collagenase ...... 60,000 patients who weresurveyed across 358 acute care hospitals randomly selected in 32countries, encomp...ss the prevalence ofVTE risk in the acute hospital care setting and to determine theproportion of at-risk patients who receive recommended prophylaxisusing ......comparison withenoxaparin, the current standard of care therapy. Patients in the RECORD3 (REgulation of Coagulation in majorOrthopaedic surgery reducing the Risk of DVT and PE) study who weretreated with rivaroxaban demonstrated a 49% relative risk reduction(RRR) (p<0.001) of the composite primary en......ld be alandmark trial in advancing the standard of care of patients athigh risk for VTE and it further establishes enoxaparin as areference treatment for VTE prophylaxis in acutely ill medicalpatients". About EXCLAIM The EXCLAIM trial is the first international, multicenter,prospective, randomized, doub......g regulatory approvals; domestic and foreignhealth care reforms and governmental laws and regulations; andtrends toward health care cost containment. A further list anddescription of these risks, uncertainties and other factors can ......es inOctober 2005 to focus on patients' and health care providers'specific needs in this disease domain. The company will alsocommercialise medicine against other viral diseases in thefuture. Contacts: Pam Van Houten Office: (908) 541-4137 CONTACT: Pam Van Houten for Tibotec Pharmaceuticals Lt...New Drugs in Multinational Study Show Promise in Fighting Drug-Resistant HIV
...rus with twoactive agents has been a mantra in HIV care for quite some time.Adding only one active agent to a patient experiencing drug failureusually results in the rapid, predictable development of resistanceto that agent. Very seldom do patients get the chance to receivetwo potent new investigational a......quibb is a global pharmaceutical and relatedhealth care products company whose mission is to extend and enhancehuman life. This press release contains "forward-looking statements" as thatterm is defined in the Private Securities Litigation Reform Act of1995 regarding product development. Such forward-loo...Stanford Researchers Find Brain Pathway of Depression in Rats
... integrates research, medicaleducation and patient care at its three institutions -- StanfordUniversity School of Medicine, Stanford Hospital & Clinics andLucile Packard Children's Hospital at Stanford. For moreinformation, please visit the Web site of the medical center'sOffice of Communication &...From Clinical Cancer Research: Rethinking Therapeutic Cancer Vaccine Trials
...ic,translational, and clinical researchers; health care professionals;and cancer survivors and advocates in the United States and morethan 70 other countries. AACR marshals the full spectrum ofexpertise from the cancer community to accelerate progress in theprevention, diagnosis and treatment of cancer th...Skin Rash Actually Signifies Better Outcomes for Pancreatic and Lung Cancer Patients
...ic,translational, and clinical researchers; health care professionals;and cancer survivors and advocates in the United States and morethan 70 other countries. AACR marshals the full spectrum ofexpertise from the cancer community to accelerate progress in theprevention, diagnosis and treatment of cancer th...Researchers Discover Method for Identifying How Cancer Evades the Immune System
...ic,translational, and clinical researchers; health care professionals;and cancer survivors and advocates in the United States and morethan 70 other countries. AACR marshals the full spectrum ofexpertise from the cancer community to accelerate progress in theprevention, diagnosis and treatment of cancer th...Major New Review Supports the Broader Potential of CeNeS COMT Inhibitor Discovery Programme
...to society and requirepatients to be under medical care for their entire lives. Despitethe availability of a variety of current antipsychotic drugs withworldwide sales exceeding USD $12 billion, cognitive disturbancesare poorly addressed by existing therapies and represent a largeunmet medical need in sch...Chi-Med Announces Positive Phase II Proof-of-Concept Data for HMPL-004 in Ulcerative Colitis
...rug,Mesalazine, the current first-line standard of care inmild-to-moderate Ulcerative Colitis. <p st... supplements and other consumer health andpersonal care products derived from Traditional Chinese Medicineand botanical ingredients. HutchisonMediPharma ...Cytokinetics Reports Additional Clinical Trials Data for Ispinesib
...ional financing ifnecessary; and that standards of care may change or others mayintroduce products or alternative therapies for the treatment ofindications which Cytokinetics drug candidates and potential drugcandidates currently or potentially target. For further informationregarding these and other risk......cts of using perifosine to improveupon the current care for these patients." In addition to the clinical posters, three pre-clinical posterswere presented, as follows: Perifosine, an Oral Bioactive Novel Akt Inhibitor, Induces In Vitro and In Vivo Anti-tumor Activity in Waldenstrom's Macroglobu......re likely to be admitted to the neonatal intensive care unit thanthose whose mothers had received the alte...ical decisionsthat might need to be made about the care of their newborn. Lyell,assistant professor of obstetrics and gynecology at the medicalschool, and Y......out Abbott Abbott is a global, broad-based health care company devoted tothe discovery, development, manufacture and marketing ofpharmaceuticals and medical products, including nutritionals,devices and diagnostics. The company employs 65,000 people andmarkets its products in more than 130 countries. Abb......al company dedicated toadvancing the treatment and care of patients by building,developing, and commercializing a portfolio of oncology products.The Company's specialized sales force currently markets threetherapeutic products and one diagnostic product to the U.S.oncology market. CAPHOSOL(R) is an advanc......s largest research-drivenpharmaceutical and health care products companies. It is a leaderin the discovery, development, manufacturing and marketing ofpharmaceuticals, vaccines, biotechnology products andnon-prescription medicines that improve the quality of life forpeople worldwide. The Company's major d......ilable might be an important overallimprovement in care for lupus nephritis patients. In line withthis, the LFA is eager to see some subset analysis, for example, ananalysis of how CellCept performs in patients of African descent,since IVC is known to be less effective for this population. The preliminar...ACE-011 Improves Multiple Myeloma Bone Disease in a Preclinical Model
... "Anti-resorptive agents are current standard of care formultiple myeloma patients yet significant unmet medical needremains as patients continue to experience serious clinicalcomplications such as bone pain and fractures", said Matthew L.Sherman, M.D., Chief Medical Officer at Acceleron. "We are excite......heir disease. Merck is committed to improvepatient care in diabetes through its significant pipeline ofinv... of womenexposed to JANUVIA while pregnant. Health care providers areencouraged to report any prenatal exposure to JANUVIA by calling thePregnancy Registry ......nthracyclines are still considered the standard of care because oftheir efficacy in several tumor types, including breast cancer,leukemia, and non-Hodgkin's lymphoma (NHL). Because of theirreversible nature of the cardiac damage that accompanies the useof currently marketed anthracyclines, patients who ar......,604 Type 2 diabetes patients, in a mainly primary care settings,and predominantly treated with Levemir® once-daily, as anadd-on therapy to any other glucose-lowering regimens, or asreplacement of a previous basal insulin. Patients wererandomized to either the “303 Algorithm” [selfadjusti...MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
...ical needfor more than 2 million Americans seeking care for Raynaud’sDisease. In addition to Vascana, MediQuest’s ongoing developmentalefforts have generated a robust pipeline that includes three drugcandidates in clinical trials, one at the pre-clinical stage andothers at the research stage.......ention, control and hospital epidemiology inhealth care settings around the globe. APIC advances its missionthrough education, research, collaboration, practice guidance,public policy, and credentialing. Visit APIC online at <a target="_blank" href="http://www.apic.org/">http://www.apic.org CONT...Neuroblastoma Expert Reviews Progress and Challenges in Fighting Difficult Pediatric Cancer
...th funding. In addition, its uniquefamily-centered care and public service programs have brought the430-bed hospital recognition as a leading advocate for children andadolescents. For more information, visit <a target="_blank" href="http://www.chop.edu/">http://www.chop.edu . Contact: Rachel Sali......ical need. The company's mission is to advance the care ofpatients suffering from life-threatening diseases worldwide.Headquartered in Foster City, California, Gilead has operations inNorth America, Europe and Australia. This press release includes forward-looking statements, withinthe meaning of the Pri......ve function, in contrastto the current standard of care designed to address the painassociated with this condition. We expect to provide an additionalupdate on the progress of this trial later in the year. We areencouraged by the data so far and are swiftly moving forward to thenext stage of clinical deve...... of womenexposed to JANUVIA while pregnant. Health care providers areencouraged to report any prenatal exp...s are more likely to have decreased renalfunction, care should be taken in dose selection in the elderly, andit may be useful to assess renal function in th......g technology isgrowing as clinical researchers and care givers realize how ourproprietary products can enhance their biologic-based therapies andservices." According to an August 2006 research report published by JainPharmaBiotech, the total value of cell-based markets was $27billion in 2005 and is expec......,604 type 2 diabetes patients, in a mainly primary care settings,and predominantly treated with Levemir(R) once-daily, as an add-ontherapy to any other glucose- lowering regimens, or as replacementof a previous basal insulin. Patients were randomized to either the"303 Algorithm" [self adjusting their Leve......ical need. The company's mission is to advance the care ofpatients suffering from life-threatening diseases worldwide.Headquartered in Foster City, California, Gilead has operations inNorth America, Europe and Australia. This press release includes forward-looking statements, withinthe meaning of the Pri...President Bush Ignores America's Plea for Support of Stem Cell Research
...Research (CAMR): "In the face of spiraling health care costs, President Bush onceagain used the stroke of his veto pen deliberately to hamper theprogress of scientific and medical research, as well as endangerthe future health and well being of the American people. Hisexecutive order directing NIH to con...